This educational program successfully reduced the frequency of major bleeding to the low levels seen in previous clinical trials. This program focused on the appropriate use of heparin and early ...

Abciximab is a potent antiplate let agent that has been shown to significantly reduce ischemic complications in patients undergoing percutaneous coronary intervention (PCI). [1,2,3,4] Abciximab ...

Nurse-led education is an essential aspect of care for patients with bleeding disorders, but there is currently a lack of research on specific strategies to improve patient self-management through ...